Titre : Cortex visuel

Cortex visuel : Questions médicales fréquentes

Termes MeSH sélectionnés :

Glymphatic System
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Cortex visuel : Questions médicales les plus fréquentes", "headline": "Cortex visuel : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Cortex visuel : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-01-27", "dateModified": "2025-04-21", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Cortex visuel" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Cortex sensorimoteur", "url": "https://questionsmedicales.fr/mesh/D066191", "about": { "@type": "MedicalCondition", "name": "Cortex sensorimoteur", "code": { "@type": "MedicalCode", "code": "D066191", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A08.186.211.200.885.287.500.814" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Cortex visuel primaire", "alternateName": "Primary Visual Cortex", "url": "https://questionsmedicales.fr/mesh/D000087642", "about": { "@type": "MedicalCondition", "name": "Cortex visuel primaire", "code": { "@type": "MedicalCode", "code": "D000087642", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A08.186.211.200.885.287.500.814.953.500" } } } ], "about": { "@type": "MedicalCondition", "name": "Cortex visuel", "alternateName": "Visual Cortex", "code": { "@type": "MedicalCode", "code": "D014793", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Andreas S Tolias", "url": "https://questionsmedicales.fr/author/Andreas%20S%20Tolias", "affiliation": { "@type": "Organization", "name": "Department of Neuroscience, Baylor College of Medicine, Houston, Texas 77030, USA; email: astolias@bcm.edu." } }, { "@type": "Person", "name": "Paul G Fahey", "url": "https://questionsmedicales.fr/author/Paul%20G%20Fahey", "affiliation": { "@type": "Organization", "name": "Department of Neuroscience, Baylor College of Medicine, Houston, Texas 77030, USA; email: astolias@bcm.edu." } }, { "@type": "Person", "name": "Jacob Reimer", "url": "https://questionsmedicales.fr/author/Jacob%20Reimer", "affiliation": { "@type": "Organization", "name": "Department of Neuroscience, Baylor College of Medicine, Houston, Texas 77030, USA; email: astolias@bcm.edu." } }, { "@type": "Person", "name": "Laura Baroncelli", "url": "https://questionsmedicales.fr/author/Laura%20Baroncelli", "affiliation": { "@type": "Organization", "name": "Institute of Neuroscience, National Research Council (CNR), I-56124 Pisa, Italy; Department of Developmental Neuroscience, IRCCS Stella Maris Foundation, I-56128 Pisa, Italy. Electronic address: baroncelli@in.cnr.it." } }, { "@type": "Person", "name": "Alexander S Ecker", "url": "https://questionsmedicales.fr/author/Alexander%20S%20Ecker", "affiliation": { "@type": "Organization", "name": "Institute for Computer Science, University Göttingen, Göttingen, Germany." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Evaluation of glymphatic-meningeal lymphatic system with intravenous gadolinium-based contrast-enhancement in cerebral small-vessel disease.", "datePublished": "2023-07-06", "url": "https://questionsmedicales.fr/article/37410111", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s00330-023-09796-6" } }, { "@type": "ScholarlyArticle", "name": "Glymphatic system impairment in corticobasal syndrome: diffusion tensor image analysis along the perivascular space (DTI-ALPS).", "datePublished": "2023-06-05", "url": "https://questionsmedicales.fr/article/37273112", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s11604-023-01454-7" } }, { "@type": "ScholarlyArticle", "name": "Evaluation of glymphatic system activity by diffusion tensor image analysis along the perivascular space (DTI-ALPS) in dementia patients.", "datePublished": "2023-04-17", "url": "https://questionsmedicales.fr/article/37066824", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1259/bjr.20220315" } }, { "@type": "ScholarlyArticle", "name": "White matter hyperintensities in migraine are not mediated by a dysfunction of the glymphatic system-A diffusion tensor imaging magnetic resonance imaging study.", "datePublished": "2023-08-18", "url": "https://questionsmedicales.fr/article/37594440", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/head.14607" } }, { "@type": "ScholarlyArticle", "name": "Motor progression phenotypes in early-stage Parkinson's Disease: A clinical prediction model and the role of glymphatic system imaging biomarkers.", "datePublished": "2023-08-09", "url": "https://questionsmedicales.fr/article/37562710", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.neulet.2023.137435" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Système nerveux", "item": "https://questionsmedicales.fr/mesh/D009420" }, { "@type": "ListItem", "position": 3, "name": "Système nerveux central", "item": "https://questionsmedicales.fr/mesh/D002490" }, { "@type": "ListItem", "position": 4, "name": "Encéphale", "item": "https://questionsmedicales.fr/mesh/D001921" }, { "@type": "ListItem", "position": 5, "name": "Prosencéphale", "item": "https://questionsmedicales.fr/mesh/D016548" }, { "@type": "ListItem", "position": 6, "name": "Télencéphale", "item": "https://questionsmedicales.fr/mesh/D013687" }, { "@type": "ListItem", "position": 7, "name": "Cerveau", "item": "https://questionsmedicales.fr/mesh/D054022" }, { "@type": "ListItem", "position": 8, "name": "Cortex cérébral", "item": "https://questionsmedicales.fr/mesh/D002540" }, { "@type": "ListItem", "position": 9, "name": "Cortex sensorimoteur", "item": "https://questionsmedicales.fr/mesh/D066191" }, { "@type": "ListItem", "position": 10, "name": "Cortex visuel", "item": "https://questionsmedicales.fr/mesh/D014793" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Cortex visuel - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Cortex visuel", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-18", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Cortex visuel", "description": "Comment diagnostiquer une lésion du cortex visuel ?\nQuels tests évaluent la fonction visuelle ?\nQuels signes indiquent une dysfonction du cortex visuel ?\nQuel rôle joue l'électroencéphalogramme (EEG) ?\nComment évaluer la vision des couleurs ?", "url": "https://questionsmedicales.fr/mesh/D014793?mesh_terms=Glymphatic+System&page=4#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Cortex visuel", "description": "Quels sont les symptômes d'une lésion du cortex visuel ?\nComment se manifeste l'agnosie visuelle ?\nQu'est-ce que l'hémianopsie ?\nQuels troubles peuvent affecter la perception des mouvements ?\nQuels symptômes indiquent une migraine occulaire ?", "url": "https://questionsmedicales.fr/mesh/D014793?mesh_terms=Glymphatic+System&page=4#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Cortex visuel", "description": "Comment prévenir les lésions cérébrales ?\nQuels examens réguliers sont recommandés ?\nComment réduire le risque de migraines ?\nQuels conseils pour protéger la santé oculaire ?\nComment gérer le stress pour prévenir les troubles visuels ?", "url": "https://questionsmedicales.fr/mesh/D014793?mesh_terms=Glymphatic+System&page=4#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Cortex visuel", "description": "Quels traitements existent pour les troubles visuels ?\nComment traiter l'agnosie visuelle ?\nQuels médicaments peuvent aider les migraines visuelles ?\nComment la rééducation visuelle fonctionne-t-elle ?\nQuels sont les traitements pour l'hémianopsie ?", "url": "https://questionsmedicales.fr/mesh/D014793?mesh_terms=Glymphatic+System&page=4#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Cortex visuel", "description": "Quelles complications peuvent survenir après une lésion du cortex visuel ?\nComment l'hémianopsie affecte-t-elle la vie quotidienne ?\nQuels risques sont associés à l'agnosie visuelle ?\nQuelles sont les conséquences des migraines fréquentes ?\nComment les troubles visuels peuvent-ils affecter l'éducation ?", "url": "https://questionsmedicales.fr/mesh/D014793?mesh_terms=Glymphatic+System&page=4#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Cortex visuel", "description": "Quels facteurs augmentent le risque de lésions cérébrales ?\nComment l'âge influence-t-il les troubles visuels ?\nQuels rôles jouent les antécédents familiaux ?\nComment le diabète affecte-t-il la vision ?\nQuels comportements augmentent le risque de migraines ?", "url": "https://questionsmedicales.fr/mesh/D014793?mesh_terms=Glymphatic+System&page=4#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une lésion du cortex visuel ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Un examen neurologique et des imageries cérébrales comme l'IRM sont utilisés." } }, { "@type": "Question", "name": "Quels tests évaluent la fonction visuelle ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests de champ visuel et d'acuité visuelle sont couramment utilisés." } }, { "@type": "Question", "name": "Quels signes indiquent une dysfonction du cortex visuel ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Des troubles de la perception visuelle, comme l'agnosie, peuvent indiquer une dysfonction." } }, { "@type": "Question", "name": "Quel rôle joue l'électroencéphalogramme (EEG) ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "L'EEG peut aider à détecter des anomalies électriques liées à des troubles visuels." } }, { "@type": "Question", "name": "Comment évaluer la vision des couleurs ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Des tests spécifiques comme le test de Ishihara sont utilisés pour évaluer la vision des couleurs." } }, { "@type": "Question", "name": "Quels sont les symptômes d'une lésion du cortex visuel ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent des troubles de la vision, des hallucinations visuelles et des difficultés de reconnaissance." } }, { "@type": "Question", "name": "Comment se manifeste l'agnosie visuelle ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "L'agnosie visuelle se manifeste par l'incapacité de reconnaître des objets malgré une vision intacte." } }, { "@type": "Question", "name": "Qu'est-ce que l'hémianopsie ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "L'hémianopsie est une perte de vision dans une moitié du champ visuel, souvent due à des lésions cérébrales." } }, { "@type": "Question", "name": "Quels troubles peuvent affecter la perception des mouvements ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Des troubles comme la simultagnosie peuvent affecter la perception des mouvements et des objets." } }, { "@type": "Question", "name": "Quels symptômes indiquent une migraine occulaire ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent des troubles visuels temporaires, comme des éclairs lumineux ou des taches." } }, { "@type": "Question", "name": "Comment prévenir les lésions cérébrales ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Éviter les traumatismes crâniens, adopter un mode de vie sain et contrôler les maladies vasculaires." } }, { "@type": "Question", "name": "Quels examens réguliers sont recommandés ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Des examens ophtalmologiques réguliers peuvent aider à détecter précocement des troubles visuels." } }, { "@type": "Question", "name": "Comment réduire le risque de migraines ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Éviter les déclencheurs connus, gérer le stress et maintenir une bonne hydratation peuvent aider." } }, { "@type": "Question", "name": "Quels conseils pour protéger la santé oculaire ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Porter des lunettes de soleil, éviter les écrans excessifs et avoir une alimentation équilibrée." } }, { "@type": "Question", "name": "Comment gérer le stress pour prévenir les troubles visuels ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Des techniques de relaxation comme le yoga et la méditation peuvent aider à réduire le stress." } }, { "@type": "Question", "name": "Quels traitements existent pour les troubles visuels ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements incluent la rééducation visuelle, la thérapie occupationnelle et parfois des médicaments." } }, { "@type": "Question", "name": "Comment traiter l'agnosie visuelle ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "La thérapie cognitive et des exercices de reconnaissance peuvent aider à traiter l'agnosie." } }, { "@type": "Question", "name": "Quels médicaments peuvent aider les migraines visuelles ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Des médicaments comme les triptans et les anti-inflammatoires peuvent soulager les migraines." } }, { "@type": "Question", "name": "Comment la rééducation visuelle fonctionne-t-elle ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "La rééducation visuelle utilise des exercices pour améliorer la perception et la reconnaissance visuelle." } }, { "@type": "Question", "name": "Quels sont les traitements pour l'hémianopsie ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Des stratégies de compensation et des exercices de champ visuel peuvent aider à gérer l'hémianopsie." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir après une lésion du cortex visuel ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications incluent des troubles cognitifs, des problèmes de coordination et des difficultés d'apprentissage." } }, { "@type": "Question", "name": "Comment l'hémianopsie affecte-t-elle la vie quotidienne ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "L'hémianopsie peut compliquer la conduite, la lecture et d'autres activités nécessitant une vision complète." } }, { "@type": "Question", "name": "Quels risques sont associés à l'agnosie visuelle ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "L'agnosie peut entraîner des difficultés dans les interactions sociales et des problèmes d'autonomie." } }, { "@type": "Question", "name": "Quelles sont les conséquences des migraines fréquentes ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Des migraines fréquentes peuvent entraîner des troubles de l'humeur, de l'anxiété et des absences au travail." } }, { "@type": "Question", "name": "Comment les troubles visuels peuvent-ils affecter l'éducation ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Les troubles visuels peuvent nuire à l'apprentissage, nécessitant des adaptations scolaires spécifiques." } }, { "@type": "Question", "name": "Quels facteurs augmentent le risque de lésions cérébrales ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les traumatismes crâniens, les AVC et les maladies neurodégénératives augmentent le risque." } }, { "@type": "Question", "name": "Comment l'âge influence-t-il les troubles visuels ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Le vieillissement peut entraîner une dégénérescence des cellules nerveuses et des troubles visuels." } }, { "@type": "Question", "name": "Quels rôles jouent les antécédents familiaux ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Les antécédents familiaux de troubles neurologiques peuvent augmenter le risque de dysfonction visuelle." } }, { "@type": "Question", "name": "Comment le diabète affecte-t-il la vision ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Le diabète peut entraîner des complications oculaires comme la rétinopathie diabétique, affectant la vision." } }, { "@type": "Question", "name": "Quels comportements augmentent le risque de migraines ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Le stress, le manque de sommeil et une mauvaise alimentation peuvent déclencher des migraines." } } ] } ] }

Sources (10000 au total)

Evaluation of glymphatic-meningeal lymphatic system with intravenous gadolinium-based contrast-enhancement in cerebral small-vessel disease.

To investigate the feasibility of using noninvasive neuroimaging methods in visualizing and evaluating the clearance of the glymphatic-meningeal lymphatic system (GMLS) in patients with arteriosclerot... This observational study recruited patients with high-burden CSVD and controls (age 50-80 years). At multiple time points before and after intravenous administration of a contrast agent, three-dimensi... A total of 20 CSVD patients and 15 controls were included. Cortical periarterial enhancement and the enhancement of enlarged perivascular spaces in the basal ganglia were respectively observed in 11 (... The impaired drainage of the GMLS in patients with high-burden CSVD could be visually evaluated using noninvasive neuroimaging methods with intravenous gadolinium-based contrast-enhancement.... Dynamic intravenous contrast-enhanced MRI could visually evaluate the impaired drainage of the glymphatic-meningeal lymphatic system in patients with high-burden cerebral small-vessel disease and coul... • Signal intensity changes in regions representing the glymphatic-meningeal lymphatic system (GMLS) can reflect the drainage function based on contrast-enhanced 3D-FLAIR and 3D T1-weighted MRI. • Impa...

Glymphatic system impairment in corticobasal syndrome: diffusion tensor image analysis along the perivascular space (DTI-ALPS).

This study aimed to evaluate the along the perivascular space (ALPS) index based on the diffusion tensor image ALPS (DTI-ALPS) in corticobasal degeneration with corticobasal syndrome (CBD-CBS) and inv... The data of 21 patients with CBD-CBS and 17 healthy controls (HCs) were obtained from the 4-Repeat Tauopathy Neuroimaging Initiative and the Frontotemporal Lobar Degeneration Neuroimaging Initiative d... The ALPS index of CBD-CBS was significantly lower than that of HC (Cohen's d = - 1.53, p < 0.005). Moreover, the ALPS index had a significant positive correlation with the mini mental state evaluation... The ALPS index of patients with CBD-CBS, which is significantly lower than that of HCs, is significantly associated with motor and cognitive functions....

Evaluation of glymphatic system activity by diffusion tensor image analysis along the perivascular space (DTI-ALPS) in dementia patients.

Dementia is a clinical syndrome caused by multiple etiologies, usually manifests with progressive and diffuse brain dysfunction. The activity of the human glymphatic system was evaluated in cases of d... We recruited 28 healthy subjects and 77 patients, including 38 with Alzheimer's disease (AD),18 with mild cognitive impairment (MCI), 28 with normal controls (NC) and 21 with vascular cognitive impair... The AD, MCI, and VCI patients showed significantly lower DTI-ALPS-index (... The evaluation of DTI-ALPS demonstrates impairment of the glymphatic system in dementia patients by decreased DTI-ALPS-index. Different from AD, the VCI patients show glymphatic drainage disorder rath... This article comprehensively covers several types of dementia and performs the comparison of VCI, AD and MCI in glymphatic system dysfunction....

White matter hyperintensities in migraine are not mediated by a dysfunction of the glymphatic system-A diffusion tensor imaging magnetic resonance imaging study.

We assessed whether brain magnetic resonance imaging (MRI) markers of glymphatic function are altered in patients with migraine and brain white matter hyperintensities (WMHs).... The glymphatic system is responsible for the outflow of waste products from the brain. An impaired glymphatic system has been associated with WMH; however, this impairment has not been shown in patien... The present cross-sectional study included consecutive patients with migraine from a single tertiary headache center. Glymphatic function was assessed by measuring the diffusion tensor imaging along t... We included 147 patients (120 women [81.6%]) with a median (interquartile range [IQR]) age of 45 (36-50) years. In all, 74 (50.3%) patients had WMHs. The median (IQR) ALPS index was similar in patient... Our results suggest that the presence of WMHs is not associated with an impairment in the glymphatic system in patients with migraine. Although negative and worthy of further confirmation, our finding...

Motor progression phenotypes in early-stage Parkinson's Disease: A clinical prediction model and the role of glymphatic system imaging biomarkers.

Substantial heterogeneity of motor symptoms in Parkinson's disease (PD) poses a challenge to disease prediction.... The aim of this study was to construct a nomogram model that can distinguish different longitudinal trajectories of motor symptom changes in early-stage PD patients.... Data on 90 patients with 5-years of follow-up were collected from the Parkinson's Progression Marker Initiative (PPMI) cohort. We used a latent class mixed modeling (LCMM) to identify distinct progres... We identified two trajectories for motor progression patterns. The first, Class 1 (Motor deteriorated group), was characterized by sustained, continuously worsening motor symptoms, and the second, Cla... This study proposes an effective nomogram to predict different motor progression patterns in early-stage PD. Furthermore, the imaging biomarker indicating glymphatic function could be an independent p...

Normal glymphatic system function in patients with new daily persistent headache using diffusion tensor image analysis along the perivascular space.

To investigate the glymphatic function in patients with new daily persistent headache (NDPH) using the diffusion tensor image analysis along the perivascular space (DTI-ALPS) method.... NDPH, a rare and treatment-refractory primary headache disorder, is poorly understood. There is limited evidence to suggest that headaches are associated with glymphatic dysfunction. Thus far, no stud... In this cross-sectional study conducted in the Headache Center of Beijing Tiantan Hospital, patients with NDPH and healthy controls were enrolled. All participants underwent brain magnetic resonance i... In total, 27 patients with NDPH (14 males, 13 females; age [mean ± standard deviation (SD)]: 36.6 ± 20.6) and 33 healthy controls (15 males, 18 females; age [mean ± SD]: 36.0 ± 10.8) were included in ... No glymphatic dysfunction was detected in patients with NDPH by means of the ALPS method. Additional studies with larger samples are needed to confirm these preliminary findings and improve the unders...

Impaired glymphatic system as evidenced by low diffusivity along perivascular spaces is associated with cerebral small vessel disease: a population-based study.

This study aims to investigate the associations of glymphatic system with the presence, severity and neuroimaging phenotypes of cerebral small vessel disease (CSVD) in a community-based population.... This report included 2219 community-dwelling people aged 50-75 years who participated in the PolyvasculaR Evaluation for Cognitive Impairment and vaScular Events cohort. The diffusivity along perivasc... The mean age was 61.3 (SD 6.6) years, and 1019 (45.9%) participants were men. The average DTI-ALPS index was 1.67±0.14. Individuals in the first quartile (Q1) of the DTI-ALPS index had higher risks of... A lower DTI-ALPS index underlay the presence, severity and typical neuroimaging markers of CSVD, implying that glymphatic impairment may interact with CSVD-related pathology in the general ageing popu... NCT03178448....

Gray matter reserve determines glymphatic system function in young-onset Alzheimer's disease: Evidenced by DTI-ALPS and compared with age-matched controls.

The diffusion tensor imaging analysis along the perivascular space (ALPS)-index can be used to model the glymphatic system in vivo.... This study explores putative mechanisms between prediction of ALPS-index and cognitive outcomes in young-onset Alzheimer's disease (YOAD) and age-matched controls (CTLs) and analyzes whether the link ... We enrolled 130 patients with YOAD and 137 CTLs. All participants underwent three-dimensional T... Patient group had significantly lower ALPS-index. The ALPS-index was associated with GM volume in the cerebellar gray, dorsolateral prefrontal, thalamus, superior frontal, amygdala and hippocampus, an... Reserved GM mediates the link between the glymphatic system and cognition. Our findings suggest that GM integrity rather than the glymphatic system could serve as a direct cognitive test scores predic...

CSF formation rate-a potential glymphatic flow parameter in hydrocephalus?

Studies indicate that brain clearance via the glymphatic system is impaired in idiopathic normal pressure hydrocephalus (INPH). This has been suggested to result from reduced cerebrospinal fluid (CSF)... CSF formation rate was estimated in 135 (75 ± 6 years old, 64/71 men/women) patients undergoing investigation for INPH. A semiautomatic CSF infusion investigation (via lumbar puncture) was performed. ... Mean CSF formation rate was 0.45 ± 0.15 ml/min (N = 135), equivalent to 27 ± 9 ml/hour. There was no difference in the mean (p = 0.362) or variance (p = 0.498) of CSF formation rate between the subjec... The average CSF formation rate in INPH was not decreased compared to the healthy reference cohort, which does not support reduced CSF turnover. This emphasizes the need to further investigate the sour...

Dynamic changes in brain glymphatic function during preoperative chemotherapy in breast cancer patients.

The current study aimed to investigate the dynamic changes in brain glymphatic function during chemotherapy in breast cancer patients (BCP) and their correlation with cognitive function.... A total of 40 healthy female participants (control group) and 80 female BCP were included. Various cognitive assessment tools were used to evaluate cognitive function. Diffusion tensor imaging along t... Following chemotherapy, BCP exhibited a significant decline in various cognitive scores. After chemotherapy, the along the perivascular space index, a parameter indicating brain glymphatic function, w... This study unveiled a close relationship between the dynamic changes in brain glymphatic function after chemotherapy and cognitive function in BCP. Our findings contribute to a deeper understanding of...